Pretargeted immuno-PET using anti-carcinoembryonic antigen (CEA) bispecific antibody and Ga-68-labeled peptide in metastatic medullary thyroid carcinoma (MTC) patients: preliminary results of an optimization clinical study

JOURNAL OF NUCLEAR MEDICINE(2014)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要